DEXAMETHASONE

Pre-Launch

dexamethasone

Teva

ANDAOPHTHALMICSUSPENSION/DROPS

Lifecycle

Pre-Launch

Clinical Trials

Data completeness

3/8 — Basic

DEXAMETHASONE (dexamethasone) by Teva is clinical pharmacology section glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Approved for dermatomyositis, polymyositis, systemic lupus erythematosus and 8 more indications.

Drug data last refreshed 13h ago

Mechanism of Action

CLINICAL PHARMACOLOGY SECTION Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Glucocorticoids cause varied metabolic effects. In addition, they modify the body's immune responses to diverse stimuli. Naturally…

Indications (11)

dermatomyositis polymyositis

Worked on DEXAMETHASONE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Clinical Trials (20)

NCT07709715Phase 3Not Yet Recruiting

A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of NXC-201 Compared With Daratumumab With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) in Newly Diagnosed Systemic AL Amyloidosis

Started Jan 2027

260 enrolled

Light Chain (AL) Amyloidosis

NCT07609706Phase 1Not Yet Recruiting

A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment

Started Oct 2026

20 enrolled

Multiple Myeloma

NCT07614022Phase 1Not Yet Recruiting

A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)

Started Oct 2026

26 enrolled

Philadelphia Positive Acute Lymphoblastic Leukemia

NCT07748689Phase 2Not Yet Recruiting

Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.

Started Oct 2026

228 enrolled

Relapsed / Refractory Multiple Myeloma

NCT07694089Phase 2Not Yet Recruiting

Steroid Avoidance, Dexamethasone, and RAGE Inhibition for Perioperative Cerebral Edema Management in High-Grade Gliomas

Started Oct 2026

80 enrolled

High-grade Gliomas (HGG)